Press releases

Varian and the Cincinnati Children's/UC Health Proton Therapy Center Complete Enrollment of FAST-01, First Human Clinical Trial of FLASH Therapy for Cancer

Varian, a Siemens Healthineers company, and the Cincinnati Children's/UC Health Proton Therapy Center today announced the completion of enrollment in FAST-01 (FeAsibility Study of FLASH...

Varian Highlights Combination with Siemens Healthineers at American Society for Radiation Oncology (ASTRO) Annual Meeting

Varian, a Siemens Healthineers company, a leading provider of cancer care technologies and solutions, will demonstrate the power of intelligent cancer care to shape the future of oncology during...

Varian Receives FDA "Breakthrough Device Designation" For Embozene® Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis

Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene® microspheres for...

News Items

Varian Installs Cyclotron at National Taiwan University Cancer Center

Installation marks milestone for first ProBeam system in Taiwan Varian announced the installation of the cyclotron for its ProBeam® proton therapy system at the National Taiwan University Cancer Center (NTUCC). The cyclotron is a core piece of…

Varian and Yonsei Cancer Center, Yonsei University Health System Sign MOU to Further Innovation to Treat Cancer Patients

Varian announced that it has entered into a three-year agreement with Yonsei Cancer Center, Yonsei University Health System to collaborate on research and development projects in the field of radiation therapy and oncology. Cancer is the leading…

Varian Partners with Sony Foundation Australia in the You Can Stay Program

Varian announced it has entered a partnership with Sony Foundation Australia to support its You Can Stay Program. The You Can Stay program provides free accommodations for cancer patients aged between 15 to 25 and their families in Australia who…

Blog posts

New Study Highlights Patient Satisfaction and Clinical Feasibility of Noona

Centerline

A clinical trial using Varian’s Noona® solution for patient engagement assesses the impact of ePROs on healthcare utilization and clinical burden.

Read more

Expanded Intracranial Applications for HyperArc Therapy

Centerline

Introduced in 2017 to help simplify SRS treatment planning and delivery for multiple brain metastases, HyperArc high-definition radiosurgery is now proving effective at treating benign intracranial lesions.

Read more

An Industry/Academic Partnership Yields Fruit: An Ultra-High Dose Rate Beam Monitoring Tool for FLASH Trials

Centerline

Varian, in partnership with the Danish Centre for Particle Therapy (DCPT) at Aarhus University Hospital and the Cincinnati Children’s Hospital/UC Health Proton Therapy Center—two members of the FlashForward™ Consortium—has tested a specialized dose monito...

Read more

Image Gallery

Brachytherapy Treatment Planning Systems
Clinac® iX medical linear accelerator, rotating
Ethos™ therapy
Ethos™ therapy